Bioextrax Past Earnings Performance

Past criteria checks 0/6

Bioextrax's earnings have been declining at an average annual rate of -45.6%, while the Machinery industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 39.7% per year.

Key information

-45.6%

Earnings growth rate

-29.8%

EPS growth rate

Machinery Industry Growth9.2%
Revenue growth rate39.7%
Return on equity-104.7%
Net Margin-714.8%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Is Bioextrax (STO:BIOEX) In A Good Position To Invest In Growth?

Apr 22
Is Bioextrax (STO:BIOEX) In A Good Position To Invest In Growth?

Companies Like Bioextrax (NGM:BIOEX) Are In A Position To Invest In Growth

Mar 07
Companies Like Bioextrax (NGM:BIOEX) Are In A Position To Invest In Growth

Is Bioextrax (NGM:BIOEX) In A Good Position To Deliver On Growth Plans?

Mar 03
Is Bioextrax (NGM:BIOEX) In A Good Position To Deliver On Growth Plans?

Is Bioextrax (NGM:BIOEX) In A Good Position To Invest In Growth?

Nov 19
Is Bioextrax (NGM:BIOEX) In A Good Position To Invest In Growth?

Revenue & Expenses Breakdown
Beta

How Bioextrax makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:BIOEX Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 233-22220
30 Sep 233-21220
30 Jun 233-20220
31 Mar 233-20210
31 Dec 222-19190
30 Sep 222-16160
30 Jun 222-14140
31 Mar 221-11110
31 Dec 211-11100
30 Sep 210-1080
30 Jun 210-870
31 Mar 210-760
31 Dec 200-650
30 Sep 200-440
30 Jun 201-440
31 Mar 201-230
31 Dec 191-230
31 Dec 181-110
31 Dec 171010
31 Dec 160000

Quality Earnings: BIOEX is currently unprofitable.

Growing Profit Margin: BIOEX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BIOEX is unprofitable, and losses have increased over the past 5 years at a rate of 45.6% per year.

Accelerating Growth: Unable to compare BIOEX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BIOEX is unprofitable, making it difficult to compare its past year earnings growth to the Machinery industry (4.9%).


Return on Equity

High ROE: BIOEX has a negative Return on Equity (-104.73%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.